Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Oncophage enters phase II sarcoma study; trial marks drug's seventh cancer indication

Oct. 23, 2000

Status of Dendreon's dendritic cell-based vaccines updated

Oct. 19, 2000

Maxamine inhibits sarcomas in preclinical study

Oct. 19, 2000

Roche begins E.U. launch for Herceptin

Oct. 11, 2000

Two dendritic/cancer cell fusion trials begun by Genzyme Molecular Oncology

Oct. 9, 2000

InterMune to commence Actimmune clinical trial in ovarian cancer

Oct. 4, 2000

FDA completes review of supplemental BLA for Rituxan

Oct. 2, 2000

O-Vax ovarian cancer vaccine awarded orphan drug status in U.S.

Sep. 29, 2000

Corixa to file Melacine BLA for stage II melanoma

Sep. 29, 2000

Immunomedics commences phase III clinical trial with LymphoCide

Sep. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...